Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer PISKEL KYLE
Adaptive Biotechnologies | SC 13G: Statement of acquisition of beneficial ownership by individuals-Rubric Capital Management LP(9.76%),David Rosen(9.76%)
Adaptive Biotechnologies | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Matrix Capital Management Company LP(0.44%),David E. Goel(0.44%)
Adaptive Biotechnologies | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(7.21%)
Adaptive Biotechnologies | SC 13G: Statement of acquisition of beneficial ownership by individuals-Nikko Asset Management Americas, Inc.(5.24%)
Adaptive Biotechnologies | 10-Q: Q3 2024 Earnings Report
Adaptive Biotechnologies | 8-K: Adaptive Biotechnologies Reports Third Quarter 2024 Financial Results
Adaptive Biotechnologies | SC 13G: Statement of acquisition of beneficial ownership by individuals-Sumitomo Mitsui Trust Group, Inc. (“SMTG”)(5.24%),Nikko Asset Management Co., Ltd. (“NAM”)(5.24%)
Adaptive Biotechnologies | SC 13G: Statement of acquisition of beneficial ownership by individuals-The Vanguard Group(7.21%)
Adaptive Biotechnologies | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Millennium Management LLC(6.4%),Millennium Group Management LLC(6.4%), etc.
Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer BOBULSKY SUSAN
Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer Taylor Stacy L
Adaptive Biotechnologies | 144: Notice of proposed sale of securities pursuant to Rule 144
Adaptive Biotechnologies | 10-Q: Q2 2024 Earnings Report
Adaptive Biotechnologies | 8-K: Adaptive Biotechnologies Reports Second Quarter 2024 Financial Results
Adaptive Biotechnologies | 8-K: Current report
Adaptive Biotechnologies | SC 13G: Statement of acquisition of beneficial ownership by individuals-Millennium Management LLC(5.3%),Millennium Group Management LLC(5.3%), etc.
Adaptive Biotechnologies | DEFA14A: Others
Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer PISKEL KYLE
Adaptive Biotechnologies | 10-Q: Q1 2024 Earnings Report